Literature DB >> 16129823

Saving islets from allograft rejection.

Terry B Strom1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16129823      PMCID： PMC1200297          DOI： 10.1073/pnas.0506079102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  13 in total

1.  The danger model: a renewed sense of self.

Authors:  Polly Matzinger
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

2.  Decoding the patterns of self and nonself by the innate immune system.

Authors:  Ruslan Medzhitov; Charles A Janeway
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

Review 3.  Clinical islet transplantation: advances and immunological challenges.

Authors:  Camillo Ricordi; Terry B Strom
Journal:  Nat Rev Immunol       Date:  2004-04       Impact factor: 53.106

4.  Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes.

Authors:  Bernhard J Hering; Raja Kandaswamy; Jeffrey D Ansite; Peter M Eckman; Masahiko Nakano; Toshiya Sawada; Ippei Matsumoto; Sung-Hee Ihm; Hui-Jian Zhang; Jamen Parkey; David W Hunter; David E R Sutherland
Journal:  JAMA       Date:  2005-02-16       Impact factor: 56.272

5.  Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans.

Authors:  K Bendtzen; T Mandrup-Poulsen; J Nerup; J H Nielsen; C A Dinarello; M Svenson
Journal:  Science       Date:  1986-06-20       Impact factor: 47.728

6.  Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice.

Authors:  Eli C Lewis; Leland Shapiro; Owen J Bowers; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-10       Impact factor: 11.205

7.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

Authors:  A M Shapiro; J R Lakey; E A Ryan; G S Korbutt; E Toth; G L Warnock; N M Kneteman; R V Rajotte
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

Review 8.  The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders.

Authors:  S N Breit; D Wakefield; J P Robinson; E Luckhurst; P Clark; R Penny
Journal:  Clin Immunol Immunopathol       Date:  1985-06

Review 9.  Heme oxygenase-1: unleashing the protective properties of heme.

Authors:  Leo E Otterbein; Miguel P Soares; Kenichiro Yamashita; Fritz H Bach
Journal:  Trends Immunol       Date:  2003-08       Impact factor: 16.687

10.  Differential roles of Mac-1+ cells, and CD4+ and CD8+ T lymphocytes in primary nonfunction and classic rejection of islet allografts.

Authors:  D B Kaufman; J L Platt; F L Rabe; D L Dunn; F H Bach; D E Sutherland
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307
View more
  6 in total

Review 1.  Immune-modulating effects of alpha-1 antitrypsin.

Authors:  Mario R Ehlers
Journal:  Biol Chem       Date:  2014-10       Impact factor: 3.915

2.  Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation.

Authors:  Isao Tawara; Yaping Sun; Eli C Lewis; Tomomi Toubai; Rebecca Evers; Evelyn Nieves; Tania Azam; Charles A Dinarello; Pavan Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

3.  Insulin degradation by acinar cell proteases creates a dysfunctional environment for human islets before/after transplantation: benefits of α-1 antitrypsin treatment.

Authors:  Gopalakrishnan Loganathan; Rajinder K Dawra; Subbiah Pugazhenthi; Zhiguang Guo; Sajjad M Soltani; Alexander Wiseman; Mark A Sanders; Klearchos K Papas; Kumaravel Velayutham; Ashok K Saluja; David E R Sutherland; Bernhard J Hering; A N Balamurugan
Journal:  Transplantation       Date:  2011-12-15       Impact factor: 4.939

Review 4.  Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors:  Eli C Lewis
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

5.  Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy.

Authors:  Efrat Ashkenazi; Boris M Baranovski; Galit Shahaf; Eli C Lewis
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

6.  Alpha-1 Antitrypsin Attenuates M1 Microglia-Mediated Neuroinflammation in Retinal Degeneration.

Authors:  Tian Zhou; Zijing Huang; Xiaowei Zhu; Xiaowei Sun; Yan Liu; Bing Cheng; Mei Li; Yizhi Liu; Chang He; Xialin Liu
Journal:  Front Immunol       Date:  2018-05-30       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.